Satisfaction and Adherence in Patients with Iron Overload Receiving Iron Chelation Therapy as Assessed by a Newly Developed Patient Instrument
- 1 January 2009
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 12 (1), 109-117
- https://doi.org/10.1111/j.1524-4733.2008.00390.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical and economic burden of infused iron chelation therapy in the United StatesTransfusion, 2007
- The impact of iron overload and its treatment on quality of life: results from a literature reviewHealth and Quality of Life Outcomes, 2006
- Health related quality of life in Malaysian children with thalassaemiaHealth and Quality of Life Outcomes, 2006
- Changing Patterns of Thalassemia WorldwideAnnals of the New York Academy of Sciences, 2005
- Myelodysplastic Syndromes — Coping with Ineffective HematopoiesisThe New England Journal of Medicine, 2005
- Impact of Azacytidine on the Quality of Life of Patients With Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2002
- Pharmacosurveillance and quality of care of thalassaemic patientsEuropean Journal of Clinical Pharmacology, 2001
- Compliance with iron chelation therapy in beta thalassaemia.Paediatric Nursing, 1998
- Sickle-cell diseaseThe Lancet, 1997
- Results of Long-Term Iron-Chelating TherapyActa Haematologica, 1996